Main > RHEUMATOLOGY > USA. P. RA>Treat.>JAK Inh. Tab.

---

USA. P. RA>Treat.>JAK Inh. Tab.'s subsections
(*) CN Approval Date: 2017. 03.15
(*) EU CE Mark Date: 2017. 03.27
(*) USA Approval Date: 2016. 02.23
Company
Generic Name: Tofacitinib
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2022. 06.28.
RTM
RTM Web-Site

USA. P. RA>Treat.>JAK Inh. Tab.'s products
This section has no products